EA
SEM

Evolution Advisers’s Select Medical SEM Stock Holding History

Evolution Advisers’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+8
New +$132 ﹤0.01% 775

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Evolution Advisers's SEM Position: Q2 2026 in Review

Evolution Advisers opened a new position in Select Medical (SEM) in Q2 2026: 8 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #775 among its holdings.

238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Evolution Advisers held 8 shares of Select Medical worth $0 as of Q2 2026.
  • Select Medical was a new Evolution Advisers position in Q2 2026.
  • Select Medical made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #775 holding.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.